Dieter Weinand - Apr 1, 2024 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Director
Signature
/s/ Shawn Glidden, attorney-in-fact
Stock symbol
REPL
Transactions as of
Apr 1, 2024
Transactions value $
$0
Form type
4
Date filed
4/3/2024, 08:00 PM
Previous filing
Jan 19, 2024
Next filing
Jan 3, 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest entirely on April 1, 2025.